Shareable Research Card

NAMI Corp. Operating Margin

This metric view shows NAMI Corp. operating margin history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q1 2021
Latest reported value
1080289%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Mar 2021
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q1 2021.
  • Latest reported value on this page: 1080289%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Operating Margin

New fact period available

Latest reported operating margin: 1080289%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Mar 2021

Page type

Metric history

Latest period

Q1 2021

SEC-backed company facts were refreshed from filings filed on 21 Nov 2024.

Benchmark Context

How Operating Margin compares with peers

NAMI Corp. sits in the top quarter of the current operating margin sample.

Compared with

Compared with 120 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 6029.4x the current sample midpoint. Operating Margin does not yet have enough prior-period data for a historical comparison on this page.

  • Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2026.
  • Nearby companies in this sample: Tecnoglass Inc. and PharmaCyte Biotech, Inc..
  • Current sample position: rank #3 of 120 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

NAMI Corp.: Operating Margin

Latest period: Q1 2021. Period end: 31 Mar 2021. Units: %. Frequency: quarterly and annual.

The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.

What This Metric Tells You

  • Shows the reported level of operating margin over 30 Jun 2018 - 31 Mar 2021.
  • Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
  • Built from 6 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.

Compare This Metric Across Companies

Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

NAMI Corp. appears at rank #3 in the latest comparison sample.

Rank Company Latest value Reported period Next step
1 Global Warming Solutions, Inc. (gwso) 99905400% Quarter - 30 Sep 2022 Open Global Warming Solutions, Inc. Operating Margin
2 Tecnoglass Inc. (tgls) 4822092% Quarter - 30 Jun 2025 Open Tecnoglass Inc. Operating Margin
3 NAMI Corp. 1080289% Quarter - 31 Mar 2021 Open NAMI Corp. Operating Margin
4 PharmaCyte Biotech, Inc. (pmcb) 396584% Quarter - 31 Jan 2014 Open PharmaCyte Biotech, Inc. Operating Margin
5 ALR Technologies SG Ltd. (alrtf) 180380% Year - 31 Dec 2022 Open ALR Technologies SG Ltd. Operating Margin
6 MUSTANG BIO, INC. (mbio) 83624% Quarter - 30 Sep 2019 Open MUSTANG BIO, INC. Operating Margin

Metric Details

Metric
Operating Margin (OperatingMargin)
Taxonomy
ratio
Units tracked
%
Frequency coverage
quarterly and annual
History range
30 Jun 2018 - 31 Mar 2021
Facts on this page
6
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Operating Margin, Quarterly (%)
Operating Margin, Annual (%)

NAMI Corp. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2021 1080289% 01 Jan 2021 31 Mar 2021
Q4 2020 1417649% 01 Oct 2020 31 Dec 2020
Q3 2020 -17787% 01 Jul 2020 30 Sep 2020
Q2 2020 -22953% 01 Apr 2020 30 Jun 2020

NAMI Corp. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2020 -22953% 01 Jul 2019 30 Jun 2020
2018 -652% 01 Jul 2017 30 Jun 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .